WHO ICTRP trial
Characterization, long-term outcome, mechanisms, and treatment of CAR-T cell…
DRKS00031604 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00031604 |
|---|---|
| Public title | Characterization, long-term outcome, mechanisms, and treatment of CAR-T cell therapy-associated neurotoxicity |
| Scientific title | Characterization, long-term outcome, mechanisms, and treatment of CAR-T cell therapy-associated neurotoxicity - COHERENCY |
| Primary sponsor | Charité Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller Neurologie |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | C83.3 C90.0 G04.2 G37.9 A85.8;Diffuse large B-cell lymphoma;Multiple myeloma;Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified;Demyelinating disease of central nervous system, unspecified;Other specified viral… |
| Interventions | Group 1: Patients who develop ICANS (immune effector cell associated neurotoxicity syndrome) after CAR-T cell therapy Group 2: Patients without ICANS (immune effector cell associated neurotoxicity syndrome) after CAR-T cell therapy Group 3… |
| Registration date | Oct 5, 2023 |
| Target size | 200 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: